Observational studyEuropean journal of haematology2026
Host Transcriptomics and Culture-Independent Testing for the Management of Febrile Neutropenia: Data From an Observational Study Conducted in a Bone Marrow Transplant Unit.
Observational study in European journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in screening, diagnosis, prognosis and personalized treatment of sepsis.European journal of microbiology & immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundManaging febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non-infectious fever. T2 magnetic resonance (T2MR) is a culture-independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay providing a likelihood of sepsis (SeptiScore).
methodsWe conducted an observational study including bone marrow transplant patients with febrile neutropenia to assess (1) the performance of T2MR versus BC (2) the performance of SeptiScore in providing valid results and diagnosing infection compared to a retrospective clinician diagnosis.
resultsWe included 90 febrile episodes. Eleven episodes had BC growing bacteria, of which 3/11 were T2Bacteria on-panel pathogens. T2Candida identified four Candida with a turnaround time of 3.0 h (IQR 3.0-3.0), significantly shorter than BC (42.4 h, IQR 39.8-50.9, p = 0.014). A SeptiScore was obtained in 86/90 cases. Febrile episodes were classified as: infectious (21/86, 24%), probably infectious (13/86, 15%), indeterminate (excluded from analysis; 40/86, 46%), non-infectious (12/86, 14%). The AUC of SeptiScore for infectious fever was 0.84 (95% CI 0.71-0.97).
conclusionDespite the short turnaround time, T2MR showed limited coverage of bloodstream pathogens. SeptiScore may help in diagnosing infectious neutropenic fever, but larger studies should clarify its clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.